ClinicalTrials.gov
public full text
Public Domain
Weight Changes After Incretin-mimetics
The goal of this study is to identify people at risk of weight regain after stopping an injectable weight loss drug. The main question the investigators aim to answer is: Can weight regain be predicted by measuring circulating Agouti-related peptide, a small protein coming from the brain?
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes#640515
- Incretin Action in Physiology and Diabetes#481725
- Incretin Effect in People With Impaired Fasting Glucose#830519
- Trajectory-Based Phenotyping After Coronary Artery Bypass Surgery#1150153
- Prediction of Acute Kidney Injury After Cardiac Surgery With Cardiopulmonary Bypass#1010854
Record · ID 879346
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive